HUP0104827A3 - Antiviral nucleoside analogues - Google Patents
Antiviral nucleoside analoguesInfo
- Publication number
- HUP0104827A3 HUP0104827A3 HU0104827A HUP0104827A HUP0104827A3 HU P0104827 A3 HUP0104827 A3 HU P0104827A3 HU 0104827 A HU0104827 A HU 0104827A HU P0104827 A HUP0104827 A HU P0104827A HU P0104827 A3 HUP0104827 A3 HU P0104827A3
- Authority
- HU
- Hungary
- Prior art keywords
- nucleoside analogues
- antiviral nucleoside
- antiviral
- analogues
- nucleoside
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title 1
- 229940127073 nucleoside analogue Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11379798P | 1998-12-23 | 1998-12-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0104827A2 HUP0104827A2 (en) | 2002-06-29 |
| HUP0104827A3 true HUP0104827A3 (en) | 2002-08-28 |
Family
ID=22351590
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0104827A HUP0104827A3 (en) | 1998-12-23 | 1999-12-22 | Antiviral nucleoside analogues |
Country Status (27)
| Country | Link |
|---|---|
| US (3) | US6358963B1 (enExample) |
| EP (1) | EP1140937B1 (enExample) |
| JP (1) | JP2002533470A (enExample) |
| KR (1) | KR100653485B1 (enExample) |
| CN (1) | CN1117751C (enExample) |
| AP (1) | AP2001002207A0 (enExample) |
| AT (1) | ATE254126T1 (enExample) |
| AU (1) | AU760875B2 (enExample) |
| BR (1) | BR9916849A (enExample) |
| CA (1) | CA2355712C (enExample) |
| CZ (1) | CZ20012352A3 (enExample) |
| DE (1) | DE69912842T2 (enExample) |
| DK (1) | DK1140937T3 (enExample) |
| EA (1) | EA004767B1 (enExample) |
| ES (1) | ES2209532T3 (enExample) |
| HU (1) | HUP0104827A3 (enExample) |
| ID (1) | ID30477A (enExample) |
| IL (1) | IL143867A0 (enExample) |
| MX (1) | MXPA01006425A (enExample) |
| NO (1) | NO20013163L (enExample) |
| NZ (1) | NZ513094A (enExample) |
| OA (1) | OA11741A (enExample) |
| PT (1) | PT1140937E (enExample) |
| TR (1) | TR200102501T2 (enExample) |
| UY (1) | UY25878A1 (enExample) |
| WO (1) | WO2000039143A2 (enExample) |
| ZA (1) | ZA200105702B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL143867A0 (en) * | 1998-12-23 | 2002-04-21 | Shire Biochem Inc | Antiviral nucleoside analogues |
| CA2399062C (en) | 2000-02-11 | 2010-01-12 | Shire Biochem Inc. | Stereoselective synthesis of nucleoside analogues |
| WO2004009595A1 (en) * | 2002-07-03 | 2004-01-29 | Triangle Pharmaceuticals, Inc. | Combination therapy with 1,3-dioxolanes and inosine monophosphate dehydrogenase inhibitors |
| ES2360096T3 (es) | 2002-08-06 | 2011-05-31 | Pharmasset, Inc. | Procedimientos de preparación de nucleosidos de 1,3-dioxolano. |
| US7706405B2 (en) * | 2002-09-12 | 2010-04-27 | Interdigital Technology Corporation | System for efficient recovery of Node-B buffered data following MAC layer reset |
| CA2505552C (en) | 2002-11-18 | 2012-06-05 | Shire Biochem Inc. | Stereoselective process for the production of dioxolane nucleoside analogues |
| DE10335061B4 (de) * | 2003-07-31 | 2005-11-17 | Wacker-Chemie Gmbh | Verfahren zur Herstellung von OH-geschützten [4-(2,6-damino-9H-purin-9-yl)-1,3-dioxolan-2-yl]methanol-Derivaten |
| CA2554782C (en) * | 2004-02-03 | 2013-08-13 | Emory University | Methods to manufacture 1,3-dioxolane nucleosides |
| US7322412B2 (en) * | 2004-08-30 | 2008-01-29 | Halliburton Energy Services, Inc. | Casing shoes and methods of reverse-circulation cementing of casing |
| ES2369619T3 (es) * | 2008-03-20 | 2011-12-02 | Befesa Salzschlacke Gmbh | Materia prima con alto contenido en arcilla de aluminio y método para su fabricación. |
| WO2012048455A1 (zh) * | 2010-10-12 | 2012-04-19 | 武汉大学 | 一种抗病毒透皮吸收贴片及其制备方法 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4041037A (en) | 1975-06-10 | 1977-08-09 | American Home Products Corporation | Antitumor derivatives of periodate-oxidized cytidine |
| US4000137A (en) | 1975-06-10 | 1976-12-28 | American Home Products Corporation | Antitumor derivatives of periodate-oxidized nucleosides |
| JPS5668674A (en) | 1979-11-08 | 1981-06-09 | Shionogi & Co Ltd | 5-fluorouracil derivative |
| JPS5738774A (en) | 1980-08-19 | 1982-03-03 | Chugai Pharmaceut Co Ltd | Uracil derivative and its preparation |
| US4479942A (en) | 1981-08-10 | 1984-10-30 | Fujisawa Pharmaceutical Co., Ltd. | Tetrahydrofurnancarboxylic acid derivatives, processes for preparation thereof and pharmaceutical compositions thereof |
| IL86007A0 (en) * | 1987-04-09 | 1988-09-30 | Wellcome Found | 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them |
| HU198933B (en) | 1987-11-02 | 1989-12-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing new xanthine derivatives and pharmaceutical compositions comprising same as active ingredient |
| US5041449A (en) | 1988-04-11 | 1991-08-20 | Iaf Biochem International, Inc. | 4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections |
| NZ228645A (en) * | 1988-04-11 | 1991-09-25 | Iaf Biochem Int | 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections |
| US5047407A (en) | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
| CA2152269C (en) | 1989-02-08 | 1999-09-21 | Bernard Belleau (Deceased) | Process for preparing substituted 1,3-oxathiolanes with antiviral properties |
| US5270315A (en) | 1988-04-11 | 1993-12-14 | Biochem Pharma Inc. | 4-(purinyl bases)-substituted-1,3-dioxlanes |
| US4987224A (en) | 1988-08-02 | 1991-01-22 | University Of Georgia Research Foundation, Inc. | Method of preparation of 2',3'-dideoxynucleosides |
| PT95516A (pt) * | 1989-10-06 | 1991-08-14 | Wellcome Found | Processo para a preparacao de derivados de 2',3'-didesoxi nucleosidos 6-substituidos |
| US5914331A (en) | 1990-02-01 | 1999-06-22 | Emory University | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| US5204466A (en) | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
| US5276151A (en) | 1990-02-01 | 1994-01-04 | Emory University | Method of synthesis of 1,3-dioxolane nucleosides |
| US5700937A (en) | 1990-02-01 | 1997-12-23 | Emory University | Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds |
| GB9009861D0 (en) | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
| DK0560794T3 (da) | 1990-11-13 | 1996-12-23 | Iaf Biochem Int | Substituerede 1,3-oxathiolaner med antivirale egenskaber |
| US5925643A (en) | 1990-12-05 | 1999-07-20 | Emory University | Enantiomerically pure β-D-dioxolane-nucleosides |
| US5179104A (en) | 1990-12-05 | 1993-01-12 | University Of Georgia Research Foundation, Inc. | Process for the preparation of enantiomerically pure β-D-(-)-dioxolane-nucleosides |
| WO1992010496A1 (en) | 1990-12-05 | 1992-06-25 | University Of Georgia Research Foundation, Inc. | ENANTIOMERICALLY PURE β-L-(-)-1,3-OXATHIOLANE NUCLEOSIDES |
| US5444063A (en) | 1990-12-05 | 1995-08-22 | Emory University | Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity |
| IL100965A (en) | 1991-02-22 | 1999-12-31 | Univ Emory | 2-Hydroxymethyl-5-(5-fluorocytosin-l-yl)-1,3-oxathiolane its resolution and pharmaceutical compositions containing it |
| WO1992018517A1 (en) | 1991-04-17 | 1992-10-29 | Yale University | Method of treating or preventing hepatitis b virus |
| GB9109506D0 (en) | 1991-05-02 | 1991-06-26 | Wellcome Found | Therapeutic nucleosides |
| GB9110874D0 (en) | 1991-05-20 | 1991-07-10 | Iaf Biochem Int | Medicaments |
| ZA923640B (en) | 1991-05-21 | 1993-02-24 | Iaf Biochem Int | Processes for the diastereoselective synthesis of nucleosides |
| GB9200150D0 (en) | 1992-01-06 | 1992-02-26 | Wellcome Found | Therapeutic nucleosides |
| US5869461A (en) | 1995-03-16 | 1999-02-09 | Yale University | Reducing toxicity of L-nucleosides with D-nucleosides |
| GB9525606D0 (en) * | 1995-12-14 | 1996-02-14 | Iaf Biochem Int | Method and compositions for the synthesis of dioxolane nucleosides with - configuration |
| US5792773A (en) | 1996-11-15 | 1998-08-11 | Yale University | L-β-dioxolane uridine analog administration for treating Epstein-Barr virus infection |
| IL143867A0 (en) * | 1998-12-23 | 2002-04-21 | Shire Biochem Inc | Antiviral nucleoside analogues |
-
1999
- 1999-12-22 IL IL14386799A patent/IL143867A0/xx unknown
- 1999-12-22 PT PT99960757T patent/PT1140937E/pt unknown
- 1999-12-22 ES ES99960757T patent/ES2209532T3/es not_active Expired - Lifetime
- 1999-12-22 AP APAP/P/2001/002207A patent/AP2001002207A0/en unknown
- 1999-12-22 KR KR1020017008068A patent/KR100653485B1/ko not_active Expired - Fee Related
- 1999-12-22 DK DK99960757T patent/DK1140937T3/da active
- 1999-12-22 TR TR2001/02501T patent/TR200102501T2/xx unknown
- 1999-12-22 HU HU0104827A patent/HUP0104827A3/hu unknown
- 1999-12-22 US US09/468,813 patent/US6358963B1/en not_active Expired - Fee Related
- 1999-12-22 ID IDW00200101622A patent/ID30477A/id unknown
- 1999-12-22 CA CA002355712A patent/CA2355712C/en not_active Expired - Fee Related
- 1999-12-22 CN CN99816209A patent/CN1117751C/zh not_active Expired - Fee Related
- 1999-12-22 OA OA1200100171A patent/OA11741A/en unknown
- 1999-12-22 DE DE69912842T patent/DE69912842T2/de not_active Expired - Lifetime
- 1999-12-22 AU AU17657/00A patent/AU760875B2/en not_active Ceased
- 1999-12-22 AT AT99960757T patent/ATE254126T1/de not_active IP Right Cessation
- 1999-12-22 WO PCT/CA1999/001229 patent/WO2000039143A2/en not_active Ceased
- 1999-12-22 JP JP2000591054A patent/JP2002533470A/ja active Pending
- 1999-12-22 MX MXPA01006425A patent/MXPA01006425A/es not_active Application Discontinuation
- 1999-12-22 CZ CZ20012352A patent/CZ20012352A3/cs unknown
- 1999-12-22 EA EA200100711A patent/EA004767B1/ru not_active IP Right Cessation
- 1999-12-22 BR BR9916849-9A patent/BR9916849A/pt not_active IP Right Cessation
- 1999-12-22 NZ NZ513094A patent/NZ513094A/en unknown
- 1999-12-22 EP EP99960757A patent/EP1140937B1/en not_active Expired - Lifetime
- 1999-12-23 UY UY25878A patent/UY25878A1/es unknown
-
2001
- 2001-06-22 NO NO20013163A patent/NO20013163L/no not_active Application Discontinuation
- 2001-06-29 US US09/893,605 patent/US6545001B2/en not_active Expired - Fee Related
- 2001-07-11 ZA ZA200105702A patent/ZA200105702B/en unknown
-
2003
- 2003-02-28 US US10/375,121 patent/US20040058893A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL346905A1 (en) | Antiviral purine derivatives | |
| GB9602028D0 (en) | Nucleoside analogues | |
| GB9815567D0 (en) | Antiviral compound | |
| IL140284A0 (en) | Adenosine derivatives | |
| HUP0105367A3 (en) | Novel nucleosides and oligonucleotide analogues | |
| GB9807354D0 (en) | Antiviral compound | |
| HUP0201708A1 (en) | The use of nucleoside analogues for treating leukemia | |
| GB9804469D0 (en) | Antiviral composition | |
| IL143867A0 (en) | Antiviral nucleoside analogues | |
| PL341819A1 (en) | Antiviral agents | |
| IL141844A0 (en) | Antiviral combinations | |
| PL338454A1 (en) | Lixofuranosilbenzimidazoles as antiviral agents | |
| GB9807355D0 (en) | Antiviral compound | |
| ZA98566B (en) | Antiviral agents | |
| GB9820417D0 (en) | Antiviral combinations | |
| GB2309969B (en) | Nucleoside analogues | |
| HK1040999A (en) | Antiviral nucleoside analogues | |
| GB9821000D0 (en) | Antiviral combinations | |
| AU7019200A (en) | Nucleoside analogues | |
| SI1117669T1 (en) | Antiviral purine derivatives | |
| GB2309968B (en) | Nucleoside analogues | |
| GB9827109D0 (en) | Antiviral combinations | |
| GB9820999D0 (en) | Antiviral combinations | |
| IL137605A0 (en) | Nucleosides | |
| GB9706424D0 (en) | Cyclic adenosine diphosphate ribose analogues |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |